Patrick G. Enright
Director at Veradermics · 18 reported transactions in 4 companies · latest trade Feb 5, 2026
Their record
Across their whole record, 3 purchases can be measured; 2 did better than the S&P 500 over the next 6 months.
Typical move +112.6%, S&P 500 +9.5% over the same days.
Their trades
Bought | Feb 5, 2026 | Feb 5, 2026 close $37.16 → Oct 28, 2026 close $143.83. S&P 500 +13.6% over the same days. | ||
Bought | Feb 5, 2026 | Feb 5, 2026 close $37.16 → Oct 28, 2026 close $143.83. S&P 500 +13.6% over the same days. | ||
Bought | Dec 11, 2025 | Dec 11, 2025 close $46.02 → Oct 23, 2026 close $27.99. S&P 500 +10.3% over the same days. | ||
Bought | Oct 9, 2025 | Oct 9, 2025 close $27.76 → Oct 23, 2026 close $26.87. S&P 500 +13.2% over the same days. |
BoughtVeradermics
$15M
Feb 5, 2026 close $37.16 → Oct 28, 2026 close $143.83. S&P 500 +13.6% over the same days.
BoughtVeradermics
$3.27M
Feb 5, 2026 close $37.16 → Oct 28, 2026 close $143.83. S&P 500 +13.6% over the same days.
BoughtVera Therapeutics
$250K
Dec 11, 2025 close $46.02 → Oct 23, 2026 close $27.99. S&P 500 +10.3% over the same days.
BoughtZenas Biopharma
$250K
Oct 9, 2025 close $27.76 → Oct 23, 2026 close $26.87. S&P 500 +13.2% over the same days.